You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 12, December 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Images in Neurology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Radiologic Imaging
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Relapsing Focal Myositis

The Localization Detected by Gallium Citrate Ga 67 Scintigraphy

Arch Neurol. 2005;62:1930-1931.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Focal myositis (FM) is a rare disease characterized by focal inflammatory enlargement in a single skeletal muscle, and usually is cured without medication.1 It is important to distinguish FM from other diseases, especially localized nodular myositis, in which multiple nodular myositis could often develop into a generalized inflammatory disease, polymyositis.2

A healthy man, aged 43 years, experienced left femoral muscle pain and enlargement in November 1997. A muscle biopsy from his left quadriceps femoris revealed inflammatory myopathy. His symptoms gradually improved without medication. In January 2004, he recognized again the gradual left femoral swelling without other complaints. In April 2004, his left thigh became 5 cm thicker than his right one, with a mild pushing pain, and he was admitted to our hospital. He had no muscle weakness. The result of a blood test showed no particular abnormality, including serum creatine kinase level, erythrocyte sedimentation rate, and antinuclear antibody and . . . [Full Text of this Article]

COMMENT


AUTHOR INFORMATION
Tatsuro Misu, MD, PhD; Maki Tateyama, MD, PhD; Ichiro Nakashima, MD, PhD; Yusei Shiga, MD, PhD; Kazuo Fujihara, MD, PhD; Yasuto Itoyama, MD, PhD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.